Clinical Trial: Trial to Evaluate Nonavalent HPV Vaccine as a Secondary Prevention in Patients Treated for Human Papilloma Virus Related High-grade Squamous Intraepithelial Lesions

U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07431502) titled 'Trial to Evaluate Nonavalent HPV Vaccine as a Secondary Prevention in Patients Treated for Human Papilloma Virus Related High-grade Squamous Intraepithelial Lesions' on Feb. 12.

Brief Summary: Randomized, placebo-controlled phase 3 trial to evaluate nonavalent HPV vaccine as a secondary prevention in patients treated for human papilloma virus related high-grade squamous intraepithelial lesions.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (HSIL) at Gynecological Site Patients With Primary HPV High-grade Squamous Intra-epithelial Lesions (...